Humans might possess dormant healing superpowers buried deep within their biology. Researchers at Texas A&M have discovered that mammalian bodies may harbor regenerative abilities previously thought lost to evolution, abilities that could theoretically be reawakened using the right biological signals.
The discovery challenges a foundational assumption in biology: that while salamanders and other creatures regrow entire limbs, humans and mammals are stuck with scarring. New work published in Nature Communications suggests that assumption may be incomplete. Instead of lacking regenerative capacity altogether, mammalian healing machinery appears to contain latent regenerative potential, simply switched off by default.
In laboratory tests, a two-step treatment protocol successfully regenerated bone, ligaments, joints, and tendons in damaged tissue. The regrown structures were not perfect copies of what was lost, but they restored the major anatomical components that had been removed. The finding marks a significant shift in how scientists think about the boundary between human healing and true regeneration.
"Why some animals can regenerate and others, particularly humans, can't is a big question that has been asked since Aristotle," said Dr. Ken Muneoka, professor at the College of Veterinary Medicine and Biomedical Sciences. "I've spent my career trying to understand that."
The key to the breakthrough lay in understanding how injury responses could be redirected. When mammals sustain injuries, their bodies typically activate fibrosis: fibroblasts rush to the wound site and create scar tissue. This response is fast and effective at preventing infection, but it locks the body into repair mode rather than true regeneration. Animals capable of regrowing limbs follow a different pathway, assembling specialized cells into a structure called a blastema, which then develops into new tissue.
Muneoka's team asked a critical question: could the same fibroblast cells that normally produce scarring be redirected to build a blastema-like structure instead?
A Two-Step Process
The researchers developed a sequential treatment using two growth factors already known to medicine. First, they applied fibroblast growth factor 2 (FGF2) after the initial wound had already healed. This timing was crucial: waiting until the body's automatic healing response had completed, then intervening to shift cellular behavior away from scarring and toward blastema formation.
Days later, they introduced bone morphogenetic protein 2 (BMP2), which signaled those redirected cells to begin building specific tissue structures. The approach essentially rewrote the body's instructions at a critical moment, changing the narrative from "seal this wound" to "build what was lost."
"This is really a two-step process," Muneoka explained. "You first shift the cells away from scarring, and then you provide the signals that tell them what to build."
Perhaps the most provocative finding was that the process did not require introducing stem cells from outside sources, as many regenerative medicine approaches assume necessary. The cells needed to drive regeneration were already present in the damaged tissue, simply behaving according to default programming. Redirecting that behavior proved possible without cellular transplantation.
"The cells that we thought to be unprogrammable, in fact are," said Dr. Larry Suva, another researcher involved in the work. "The capacity is not absent -- it's just obscured."
The scientists also observed that cells could be instructed to create structures in locations where they would not normally appear, a process called positional re-specification. Cells destined to build one type of tissue could be reprogrammed to rebuild a different structure following injury. This flexibility suggested deeper reserves of biological potential than current healing models acknowledged.
The practical implications begin modestly. Both growth factors used in the study already exist in the medical toolkit. BMP2 carries FDA approval for certain applications, while FGF2 is undergoing multiple clinical trials. That regulatory history could accelerate the path toward human testing compared to entirely novel therapies.
Even before achieving complete regeneration, the approach may offer immediate benefits by reducing scarring and improving how tissue repairs itself. Shifting the body's response away from fibrosis, even partially, could transform healing outcomes for injury patients.
"People should start thinking about using these signals during the healing process," Muneoka said. "Even shifting the response slightly away from scarring could have real benefits."
The study suggests regeneration depends on multiple biological pathways working in concert rather than a single master switch. The complexity means there is much more ground to explore, but it also means there may be multiple leverage points for intervention. Each discovery about how regeneration operates opens new avenues for enhancing the mammalian healing response.
Author Jessica Williams: "If mammals have been sitting on regenerative capacity this whole time, waiting only for the right biological instructions, we've been thinking about the wrong problem for centuries."
Comments